Clean Label Products, Organic & Natural Ingredients, Allergen-Free Options, Global Flavors & Ethnic Diversity, and ...

Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device ...

Abbott Laboratories ABT reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.34, in line with the Zacks ...

Welcome to Abbott's fourth quarter 2024 earnings conference call. [Operator instructions] This call is being recorded by ...

Morgan Stanley analyst Patrick Wood maintained a Hold rating on Abbott Laboratories (ABT – Research Report) yesterday and set a price target of ...

Formulas marketed for toddlers are a burgeoning business, but pediatricians have long recommended against their use.

The lawsuit accuses the formula maker of deceptively marketing the milks to make them seem like the next recommended step for toddlers.

For the full calendar of 2024, Abbott recorded sales of $41.95 billion, following the launches last year of a new heart valve ...

Abbott has won an innovation award for Lingo, its first consumer biowearable over-the-counter device that helps people ...

Abbott dismissed the allegations as "without merit." "Abbott's representations of its toddler nutrition products are accurate, and our claims are well-supported," the company said in a statement ...

The company’s projected adjusted diluted EPS for 2025 is between $5.05 and $5.25, marking double-digit growth at the midpoint. Abbott’s first-quarter 2025 adjusted EPS is expected to be between $1.05 ...